Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06568887

Effectiveness of 5% Dextrose Water Versus Corticosteroid Injection for Pain Management of SJD

Effectiveness of 5% Dextrose Water (D/W) Versus Corticosteroid Injection for Pain Management of Sacroiliac Joint Dysfuntion

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Superior University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The sacroiliac joint (SIJ) is identified as a potential origin of low back pain and referred pain to the lower limb, with a prevalence rate ranging from 7% to 30%. Typically, SIJ pain manifests in the buttock and occasionally extends to the posterior aspect of the ipsilateral thigh, resembling pain originating from lumbar spine sources, such as the zygapophysial joints or intervertebral discs.

Detailed description

For Sacroiliac Joint Dysfunction (SIJD) by examining the comparative effectiveness of two distinct interventions: the innovative 5% Dextrous Water (D/W) solution and the conventional corticosteroid injection. With corticosteroids associated with well-documented side effects and concerns about long-term use, the exploration of 5% D/W is particularly timely and holds promise as a potentially safer alternative.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTDextrose WaterIndividuals in this group will receive three injections of 5% dextrose water per week for six weeks period to treat their pain in sacroiliac joint and then their responce will b documented.
COMBINATION_PRODUCTCorticosteroid InjectionIndividuals in this group will receive three corticosteroid injections per week for a period of six weeks to treat their pain in Sacroiliac joint and then their responce will also be documented.

Timeline

Start date
2023-10-30
Primary completion
2024-05-01
Completion
2024-09-30
First posted
2024-08-23
Last updated
2024-08-23

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06568887. Inclusion in this directory is not an endorsement.